
|Articles|March 20, 2008
DigiFab production increased to combat temporary antibody shortage
Fougera and Protherics announce increased DigiFab production to counteract shortage.
Advertisement
Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
4
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
5






























